Buy and Sell for Free! Tuesday, April 11, 2000
fesub.gif (4328 bytes)
Full Story
 Intel IT update
fe.gif (834 bytes)
India's first e-business paper
flnews.gif (5153 bytes)
Search FE
BSE Quotes
NSE Quotes
Think Tank
This week we focus on a complete analysis of the
e-tailing industry

Pharma brands in major ranking rejig 

Anju Ghangurde  
Mumbai, April 10: There has been a significant reshuffle in the rankings of India Pharma Inc's top-selling drug brands as per the latest ORG rankings. Except for Pfizer's multi-vitamin megabrand Becosules, Ranbaxy's antibiotic Sporidex and Himalaya Drugs' Liv-52, there has been shift in the MAT (moving annual total) rankings of all the remaining top 10 drug brands, the biggest losers being Heinz India's Glucon D and Glaxo's Betnesol.

Glucon D and Betnesol (for supression of anti-inflammatory disorders) have moved down to 29th rank and 11th rank, respectively, as per ORG MAT data for February 2000 against their January 1999 (MAT) rankings of 10 and four.Glaxo Wellcome, however, continues to top the ranking charts, while Heinz has fallen to 44th position from 33 (MAT) in January 1999.

New entrants into the top 10 list include Knoll Pharmaceuticals' antacid Digene (up to 10th position from 15th in January 1999) and Unichem Laboratories' Ampoxin (up to ninth position from 17 in January 1999).

ORG data indicates that Becosules (launched as early as January 1970) continues to rule the roost at the top of the medicine chart. However, its sales have declined to Rs 70.56 crore from Rs 80.38 crore in January 1999, though ORG data does not reflect institutional sales figures. Sporidex, on the other hand, has gained with the turnover touching Rs 63 crore in February 2000 from Rs 58 crore in January 1999.

Meanwhile, all the other 10 best-selling drugs including popular brands like Pfizer's cough syrup brand, Corex, and Alembic's erythromycin brand Althrocin have juggled positions amongst themselves. Corex has moved up to number two position as per MAT figures for February 2000 (it was number three in January 1999), while Althrocin has gone down a slot to number three rank (it was at number two in January 1999).

Another silent mover appears to be Alkem Laboratories' Taxim which has been clawing its way up. The brand moved up to fourth position in February 2000 from sixth in January 1999. Novartis' Voveran (for rheumatism) moved up two notches to seventh position while Cifran (ciprofloxacin) from Ranbaxy inched up by one slot to sixth rank.ORG (MAT) data also highlights that corporate movers - Knoll Pharma, Sun Pharma, Cadila Pharma and Dr Reddy's Labs --have climbed their way up seventh, eighth, ninth and 16th ranks, respectively.

Copyright © 2000 Indian Express Newspapers (Bombay) Ltd.

- Lead Stories | Corporate | Infrastructure | Commodities | Economy/Finance | BSE Today | NSE/ Markets | Strategy | Convergence | After Hours top.gif (150 bytes)Top
flame.jpg (1068 bytes) Copyright 1999: Indian Express Newspaper(Bombay) Ltd. All rights reserved throughout the world.
This entire edition is compiled in Mumbai by The Indian Express Online Media Limited, a division of
The Indian Express Group of Newspapers. Managed by The Indian Express Online Media Limited and hosted by CerfNet.